https://www.belgiumhealthreview.com/article/908828559-nyxoah-to-release-first-quarter-2026-financial-results-on-may-12-2026 Belgium Health Review en PressRelease 2026-04-28T20:05:00+00:00 Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026 https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/logo-nyxoah-rgb-png.png https://www.belgiumhealthreview.com/article/908828610-nyxoah-publiera-ses-r-sultats-financiers-du-premier-trimestre-2026-le-12-mai-2026 Belgium Health Review en PressRelease 2026-04-28T20:05:00+00:00 Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2026 le 12 Mai 2026 https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/ https://www.belgiumhealthreview.com/article/908828702-financial-and-strategic-review-annual-general-meeting-and-trading-halt Belgium Health Review en PressRelease 2026-04-28T20:00:00+00:00 Financial and Strategic Review, Annual General Meeting, and Trading Halt https://ml-eu.globenewswire.com/media/b5ba012f-32c9-4567-bb3a-c01eb27aa4b0/small/sequana-rgb-300-png.png https://www.belgiumhealthreview.com/article/908712762-coultreon-biopharma-raises-125-million-in-series-a-financing-to-advance-immunology-pipeline Belgium Health Review en PressRelease 2026-04-28T11:00:00+00:00 Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline https://ml-eu.globenewswire.com/media/17b98091-8f01-43aa-887f-f8da2bb83f52/small/coultreon-logo-jpg.jpg